BIO 300 Non-Small Cell Lung Cancer Study
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase I, Open-Label, 2 Part Multicentre Study to Assess the Safety and Efficacy of Olaparib in Combination With Carboplatin in Patients With Advanced HER-2 Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Pembro/Carbo/Taxol in Endometrial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Carboplatin and Docetaxel in Triple Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Improved Breast Cancer Therapy (I-BCT-1) in the Neoadjuvant and Metastatic Setting
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Comparison of Single-Agent Carboplatin vs the Combination of Carboplatin and Everolimus for the Treatment of Advanced Triple-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Taladegib, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Localized Esophageal or Gastroesophageal Junction Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
MPDL3280A With Chemoradiation for Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembrolizumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Modulation of the Expression of Papillomavirus (HPV) Oncoproteins to Major the Radiosensitivity: Trial Combining an Antiviral Agent VISTIDE and Radiochemotherapy in Cervical Cancers
- Status
- COMPLETED
- Phase
- PHASE1
AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study on Neoadjuvant Therapy for Her-2 Positive Breast Cancer and the Prognosis by Detecting CTCs
- Status
- UNKNOWN
- Phase
- PHASE2
Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the Esophagus
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol
- Status
- COMPLETED
- Phase
- PHASE3
Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Pilot Study of Response-Driven Adaptive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- NA